330 related articles for article (PubMed ID: 14657533)
1. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program.
Gloeckler Ries LA; Reichman ME; Lewis DR; Hankey BF; Edwards BK
Oncologist; 2003; 8(6):541-52. PubMed ID: 14657533
[TBL] [Abstract][Full Text] [Related]
2. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.
Hayat MJ; Howlader N; Reichman ME; Edwards BK
Oncologist; 2007 Jan; 12(1):20-37. PubMed ID: 17227898
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
4. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
5. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
7. Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013.
Bright CJ; Rea DW; Francis A; Feltbower RG
Cancer Epidemiol; 2016 Oct; 44():186-194. PubMed ID: 27632243
[TBL] [Abstract][Full Text] [Related]
8. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
9. Cancer treatment and survivorship statistics, 2019.
Miller KD; Nogueira L; Mariotto AB; Rowland JH; Yabroff KR; Alfano CM; Jemal A; Kramer JL; Siegel RL
CA Cancer J Clin; 2019 Sep; 69(5):363-385. PubMed ID: 31184787
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?
Merrill RM; Dearden KA
Cancer Causes Control; 2004 Dec; 15(10):1027-34. PubMed ID: 15801487
[TBL] [Abstract][Full Text] [Related]
13. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
14. Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013.
Noone AM; Cronin KA; Altekruse SF; Howlader N; Lewis DR; Petkov VI; Penberthy L
Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):632-641. PubMed ID: 27956436
[No Abstract] [Full Text] [Related]
15. Paediatric testicular cancer: an updated review of incidence and conditional survival from the Surveillance, Epidemiology and End Results database.
Alanee S; Shukla A
BJU Int; 2009 Nov; 104(9):1280-3. PubMed ID: 19388997
[TBL] [Abstract][Full Text] [Related]
16. Bladder malignancies in children aged <18 years: results from the Surveillance, Epidemiology and End Results database.
Alanee S; Shukla AR
BJU Int; 2010 Aug; 106(4):557-60. PubMed ID: 20015324
[TBL] [Abstract][Full Text] [Related]
17. Conditional relative survival among long-term survivors of adolescent and young adult cancers.
Anderson C; Smitherman AB; Nichols HB
Cancer; 2018 Jul; 124(14):3037-3043. PubMed ID: 29742278
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
19. Leukemias, myeloma, and other lymphoreticular neoplasms.
Hernández JA; Land KJ; McKenna RW
Cancer; 1995 Jan; 75(1 Suppl):381-94. PubMed ID: 8001009
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of islet cell carcinoma.
Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
